Treatment of rhabdomyosarcoma in children and adolescent from four low health expenditures average rates countries
By:
References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394424. doi: 10.3322/caac.21492
- Vassal G, Fitzgerald E, Schrappe M, Arnold F, Kowalczyk J, Walker D, et al. Challenges for children and adolescents with cancer in Europe: the SIOP-Europe agenda. Pediatr Blood Cancer 2014; 61: 1551-7. doi: 10.1002/ pbc.25044
- Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al. Childhood cancer survival in Europe 1999-2007: Results of EUROCARE-5-a population-based study. Lancet Oncol 2014; 15: 35-47. doi: 10.1016/S1470-2045(13)70548-5
- Kowalczyk JR, Samardakiewicz M, Fitzgerald E, Essiaf S, Ladenstein R, Vassal G, et al. Towards reducing inequalities: European standards of care for children with cancer. Eur J Cancer 2014; 50: 481-5. doi: 10.1016/j. ejca.2013.11.004
- Stary J, Zimmermann M, Campbell M, Castillo L, Dibar E, Donska S, et al. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002. J Clin Oncol 2014; 32: 174-84. doi: 10.1200/JCO.2013.48.6522
- Pasquali S, Bonvalot S, Tzanis D, Casali PG, Trama A, Gronchi A, et al. RARECARENet Working Group. Treatment challenges in and outside a network setting: Soft tissue Sarcomas. Eur J Surg Oncol 2019; 45: 31-9. doi: 10.1016/j.ejso.2017.09.015
- International incidence of childhood cancer. Volume III. Steliarova-Foucher E, Colombet M, Ries LAG, Hesseling P, Moreno F, Shin HY, et al, editors. Lyon, France: International Agency for Research on Cancer; 2017. [cited 2020 May 15]. Available at: http://iicc.iarc.fr/results/
- Stevens MC, Rey A, Bouvet N, Ellershaw C, Flamant F, Habrand JL, et al. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology - SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol 2005; 23: 2618-28. doi: 10.1200/JCO.2005.08.130
- Bisogno G, De Salvo GL, Bergeron C, Gallego Melcón S, Merks JH, Kelsey A, et al; European paediatric Soft tissue sarcoma Study Group. Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 2019; 20: 1566-75. doi: 10.1016/S1470-2045(19)30617-5
- Breneman JC, Lyden E, Pappo AS, Link MP, Anderson JR, Parham DM, et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 2003; 21: 78-84. doi: 10.1200/JCO.2003.06.129
- Koscielniak E, Harms D, Henze G, Jürgens H, Gadner H, Herbst M, et al. Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 1999; 17: 3706-19. doi: 10.1200/JCO.1999.17.12.3706
- Oberlin O, Rey A, Lyden E, Bisogno G, Stevens MC, Meyer WH, et al. Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol 2008; 26: 2384-9. doi: 10.1200/JCO.2007.14.7207
- Bisogno G, Jenney M, Bergeron C, Gallego Melcón S, Ferrari A, Oberlin O, et al. Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet Oncol 2018; 19: 1061-71. doi: 10.1016/S1470-2045(18)30337-1
- Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 2001; 19: 3091-102. doi: 10.1200/ JCO.2001.19.12.309
- Flamant F, Rodary C, Rey A, Praquin MT, Sommelet D, Quintana, et al. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology MMT84. Eur J Cancer 1998; 34: 1050-62. doi: 10.1016/s0959-8049(98)00024-0
- Koscielniak E, Harms D, Henze G, Jürgens H, Gadner H, Herbst M, et al. Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 1999; 17: 3706-19. doi: 10.1200/JCO.1999.17.12.3706
- Cecchetto G, Carli M, Sotti G, Bisogno G, Dall’Igna P, C Boglino, et al. Importance of local treatment in pediatric soft tissue sarcomas with microscopic residual after primary surgery: results of the Italian Cooperative Study RMS-88. Med Pediatr Oncol 2000; 34: 97-101. doi: 10.1002/(sici)1096-911x(200002)34:2<;97::aid-mpo4>3.0.co;2-8
- Jereb B, Anžič J. Pediatric oncology in Slovenia. Pediatric Hematol Oncol 1996; 13: 401-4. doi: 10.3109/08880019609030851
- Ferrari A, Bisogno G, Casanova M, Meazza C, Piva L, Cecchetto G, et al. Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group. J Clin Oncol 2002; 20: 449-55. doi: 10.1200/JCO.2002.20.2.449
- Stewart RJ, Martelli H, Oberlin O, Rey A, Bouvet N, Spicer RD, et al. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology. J Clin Oncol 2003; 21: 793-8. doi: 10.1200/JCO.2003.06.040
- Merks JH, De Salvo GL, Bergeron C, Bisogno G, De Paoli A, Ferrari A, et al. Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups. Ann Oncol 2014; 25: 231-6. doi: 10.1093/annonc/mdt426
- Bisogno G, De Rossi C, Gamboa Y, Sotti G, Ferrari A, Dallorso S, et al. Improved survival for children with parameningeal rhabdomyosarcoma: Results from the AIEOP soft tissue sarcoma committee. Pediatr Blood Cancer 2008; 50: 1154-8. doi: 10.1002/pbc.2152
- Minard-Colin V, Kolb F, Saint-Rose C, Fayard F, Janot F, Rey A, et al. Impact of extensive surgery in multidisciplinary approach of pterygopalatine/ infratemporal fossa soft tissue sarcoma. Pediatr Blood Cancer 2013; 60: 928-34. doi: 10.1002/pbc.24374
- Chargari C, Haie-Meder C, Guérin F, Minard-Colin V, de Lambert G, Mazeron R, et al. Brachytherapy combined with surgery for conservative treatment of children with bladder neck and/or prostate rhabdomyosarcoma. Int J Rad Oncol 2017; 98: 352-9. doi: 10.1016/j.ijrobp.2017.02.026
- Bisogno G, Pastore G, Perilongo G, Sotti G, Cecchetto G, Dallorso S, et al. Long-term results in childhood rhabdomyosarcoma: A report from the Italian cooperative study RMS 79. Pediatr Blood Cancer 2012; 58: 872-6. doi: 10.1002/pbc.23292
Language: English
Page range: 455 - 460
Submitted on: Jun 18, 2020
Accepted on: Sep 8, 2020
Published on: Oct 21, 2020
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2020 Maja Cesen Mazic, Aleksandra Bonevski, Martina Mikeskova, Emilia Mihut, Gianni Bisogno, Janez Jazbec, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.